Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Salim Joubran"'
Autor:
Alexander Levitzki, Mark X. Sliwkowski, Anat Globerson Levin, Gabriel Mizraji, Shang-Fan Yu, Jeffrey Lau, Nufar Edinger, Shoshana Klein, Anna Sagalov, Salim Joubran, Alexei Shir, Maya Zigler
Supplementary Material and methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ba8b54e7bdb6781ac551d6c860fe44e
https://doi.org/10.1158/2326-6066.22538000.v1
https://doi.org/10.1158/2326-6066.22538000.v1
Autor:
Alexander Levitzki, Mark X. Sliwkowski, Anat Globerson Levin, Gabriel Mizraji, Shang-Fan Yu, Jeffrey Lau, Nufar Edinger, Shoshana Klein, Anna Sagalov, Salim Joubran, Alexei Shir, Maya Zigler
The development of targeted therapies that affect multiple signaling pathways and stimulate antitumor immunity is greatly needed. About 20% of patients with breast cancer overexpress HER2. Small molecules and antibodies targeting HER2 convey some sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e4fb8c734f4b546b57e4f28878440a6
https://doi.org/10.1158/2326-6066.c.6548633.v1
https://doi.org/10.1158/2326-6066.c.6548633.v1
Autor:
Alexander Levitzki, Mark X. Sliwkowski, Anat Globerson Levin, Gabriel Mizraji, Shang-Fan Yu, Jeffrey Lau, Nufar Edinger, Shoshana Klein, Anna Sagalov, Salim Joubran, Alexei Shir, Maya Zigler
Supplementary Figure illustrating the difference in cytokine mRNA and protein expression following treatment of BT-474 with pIC/PPHAffibody and pIC/PPCys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67253c4e105aeefd9eb88b5d1004811b
https://doi.org/10.1158/2326-6066.22538006.v1
https://doi.org/10.1158/2326-6066.22538006.v1
Autor:
Alexander Levitzki, Mark X. Sliwkowski, Anat Globerson Levin, Gabriel Mizraji, Shang-Fan Yu, Jeffrey Lau, Nufar Edinger, Shoshana Klein, Anna Sagalov, Salim Joubran, Alexei Shir, Maya Zigler
Supplementary Figure demonstrating the effect of pIC/PPHAffibody treatment on RENCA HER2 cell survival in vitro and in vivo by immunohistochemistry staining for c-caspase-3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98c327d560c5eb757ca4aa54cf6e444d
https://doi.org/10.1158/2326-6066.22538003.v1
https://doi.org/10.1158/2326-6066.22538003.v1
Autor:
Alexander Levitzki, Mark X. Sliwkowski, Anat Globerson Levin, Gabriel Mizraji, Shang-Fan Yu, Jeffrey Lau, Nufar Edinger, Shoshana Klein, Anna Sagalov, Salim Joubran, Alexei Shir, Maya Zigler
Supplementary Figure illustrating the expression of TLR3 in cell line that deferentially express HER2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25a84f4935ce16c039a4dc8b54464c73
https://doi.org/10.1158/2326-6066.22538009
https://doi.org/10.1158/2326-6066.22538009
Autor:
Dolev Zamir, Israel Alshanski, Shir Zorsky, Moshe Bentolila, Salim Joubran, Chaim Gilon, Agata Gitlin-Domagalska, Mattan Hurevich
Publikováno v:
Organic Process Research & Development. 22:1318-1322
The brittle nature of the polymer beads used in SPPS dictates mild mixing techniques with low mass transfer. We demonstrate that vigorous overhead mechanical stirring with superior mass transfer properties kept the beads intact and significantly acce
Autor:
Salim Joubran, Alexander Levitzki, Nufar Edinger, Anna Sagalov, Yael Langut, Shoshana Klein, Efrat Flashner-Abramson, Samarasimhareddy Mamidi, Alexei Shir, Maya Zigler, Alaa Talhami
Publikováno v:
Proceedings of the National Academy of Sciences. 114:13655-13660
There is an urgent need for an effective treatment for metastatic prostate cancer (PC). Prostate tumors invariably overexpress prostate surface membrane antigen (PSMA). We designed a nonviral vector, PEI-PEG-DUPA (PPD), comprising polyethylenimine-po
Autor:
Mark X. Sliwkowski, Alexander Levitzki, Nufar Edinger, Anna Sagalov, Gabriel Mizraji, Shoshana Klein, Shang-Fan Yu, Anat Levin, Alexei Shir, Jeffrey Lau, Maya Zigler, Salim Joubran
Publikováno v:
Cancer Immunology Research. 4:688-697
The development of targeted therapies that affect multiple signaling pathways and stimulate antitumor immunity is greatly needed. About 20% of patients with breast cancer overexpress HER2. Small molecules and antibodies targeting HER2 convey some sur
Autor:
Maya Zigler, Anna Sagalov, Nufar Edinger, Alexei Shir, Neta Pessah, Yair Razvag, Shoshana Klein, Alexander Levitzki, Meital Reches, Salim Joubran
Publikováno v:
Bioconjugate Chemistry
The delivery of nucleic acids into cells is an attractive approach for cancer therapy. Polyethylenimine (PEI) is among the most efficient nonviral carriers. Recent studies have demonstrated that PEI can be conjugated to targeting ligands, such as epi
Autor:
Salim Joubran, Laurence Briant-Longuet, Noam S. Freeman, Mattan Hurevich, Martine Bardy, Amnon Hoffman, Christian Devaux, Elena Britan-Rosich, Chaim Gilon, Avi Swed, Moshe Kotler, Shira Cohen
Publikováno v:
Bioorganic and Medicinal Chemistry
Bioorganic and Medicinal Chemistry, Elsevier, 2010, 18 (15), pp.5754-5761. ⟨10.1016/j.bmc.2010.04.053⟩
Bioorganic and Medicinal Chemistry, Elsevier, 2010, 18 (15), pp.5754-5761. ⟨10.1016/j.bmc.2010.04.053⟩
International audience; Rational conversion of noncontinuous active regions of proteins into a small orally bioavailable molecule is crucial for the discovery of new drugs based on inhibition of protein-protein interactions. We developed a method tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::509709cec96f1ac268e954364040c634
https://hal.archives-ouvertes.fr/hal-00505767
https://hal.archives-ouvertes.fr/hal-00505767